2011Ä꿼ÑÐÓ¢Óﱸ¿¼£ºÓ¢ÓïÔĶÁרÏîÌØѵ(4)[1]

¡¾ÍøÂç×ÛºÏ - Ñо¿Éú¿¼ÊÔ(¿¼ÑÐ)ÊÔÌâ¡¿
With medicine, the boon of biotechnology has been obvious. People readily accept it when they see how better drugs and clearer diagnoses improve their lives. Why is it different when biotech is applied to agriculture? The answer is that the clearest gains from the current crop of genetically modified (GM) plants go not to consumers but to producers. Indeed, that was what their developers intended: an appeal to farmers offered the purveyors of GM technology the best hope of a speedy return. For consumers, especially in the rich world, the benefits of superª²yielding soybeans are less clear: the world, by and large, already has too much food in its stores; developing countries principally lack money, not food as much, Yet companies still pitch their products as a cure for malnutrition even though little that they are doing can justify such a noble claim. In hyping the technology as the only answer to everything from pest control to world hunger, the industry has fed the popular view that